Projects Directory



Cartilage Research

Advisor: Scott Hazelwood and Steve Klisch
Students: Nathan Balcom

In vitro cultures with insulin-like growth factor-1 (IGF-1) and transforming growth factor-β1 (TGF-β1) have previously been shown to differentially modulate the growth of immature bovine articular cartilage. IGF-1 stimulates expansive growth yet decreases compressive moduli and increases compressive Poisson's ratios, whereas TGF-β1 maintains tissue size, increases compressive moduli, and decreases compressive Poisson's ratios. The current study's hypothesis was that sequential application of IGF-1 and TGF-β1 during in vitro culture produces geometric and compressive mechanical properties that lie between extreme values produced when using either growth factor alone. Immature bovine articular cartilage specimens were harvested and either untreated (D0, i.e., day zero) or cultured in vitro for either 6 days with IGF-1 (D6 IGF), 12 days with IGF-1 (D12 IGF), or 6 days with IGF-1 followed by 6 days with TGF-β1 (D12 SEQ, i.e., sequential). Following treatment, all specimens were tested for geometric, biochemical, and compressive mechanical properties. Relative to D0, D12 SEQ treatment enhanced volumetric growth, but to a lower value than that for D12 IGF. Furthermore, D12 SEQ treatment maintained compressive moduli and Poisson's ratios at values higher and lower, respectively, than those for D12 IGF. Considering the previously described effects of 12 days of treatment with TGF-β1 alone, D12 SEQ induced both growth and mechanical property changes between those produced with either IGF-1 or TGF-β1 alone. The results suggest that it may be possible to vary the durations of select growth factors, including IGF-1 and TGF-β1, to more precisely modulate the geometric, biochemical, and mechanical properties of immature cartilage graft tissue in clinical repair strategies.

Blood Vessel Mimics

Advisor: Kristen O’Halloran Cardinal
Students: Scott Herting

“Blood Vessel Mimics” (BVMs) are tissue engineered models of human blood vessels grown in vitro for the purpose of being used in preclinical evaluation of medical devices.  Cal Poly’s Tissue Engineering Lab, under the guidance of Dr. Kristen O’Halloran Cardinal, focuses on cultivating these BVMs for use as an intermediate step between traditional in vitro and in vivo evaluation of intravascular devices such as coronary stents.  Benefits of this model in the testing process include the use of human cells to create a more physiologically relevant testing environment, the ability to control and manipulate the testing environment, and the potential to reduce the number of animals necessary for device testing.